Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Biochemical Pharmacology
|
January 12, 1996
Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin
E Hamel, C M Lin, J Plowman, et al.
Journal of the National Cancer Institute
|
December 21, 1994
Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents
W W van Osdol, T G Myers, K D Paull, et al.
Journal of Medicinal Chemistry
|
July 8, 1994
Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro
J Jurayj, R D Haugwitz, R K Varma, et al.
The Journal of Biological Chemistry
|
August 25, 1991
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
R L Bai, K D Paull, C L Herald, et al.
British Journal of Cancer
|
March 26, 1998
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity
T D Bradshaw, S Wrigley, D F Shi, et al.
Cancer Treatment Reports
|
May 1, 1986
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice
J Plowman, V L Narayanan, D Dykes, et al.
Journal of the National Cancer Institute
|
October 23, 1997
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
K Wosikowski, D Schuurhuis, K Johnson, et al.
Biochemical Pharmacology
|
May 11, 1995
Azatoxin derivatives with potent and selective action on topoisomerase II
F Leteurtre, D L Sackett, J Madalengoitia, et al.
Biochemical Pharmacology
|
October 7, 1994
Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin
K Gharehbaghi, A Sreenath, Z Hao, et al.
Journal of the National Cancer Institute
|
July 19, 1989
Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm
K D Paull, R H Shoemaker, L Hodes, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Biochemical Pharmacology
|
January 12, 1996
Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin
E Hamel, C M Lin, J Plowman, et al.
Journal of the National Cancer Institute
|
December 21, 1994
Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents
W W van Osdol, T G Myers, K D Paull, et al.
Journal of Medicinal Chemistry
|
July 8, 1994
Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro
J Jurayj, R D Haugwitz, R K Varma, et al.
The Journal of Biological Chemistry
|
August 25, 1991
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
R L Bai, K D Paull, C L Herald, et al.
British Journal of Cancer
|
March 26, 1998
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity
T D Bradshaw, S Wrigley, D F Shi, et al.
Cancer Treatment Reports
|
May 1, 1986
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice
J Plowman, V L Narayanan, D Dykes, et al.
Journal of the National Cancer Institute
|
October 23, 1997
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
K Wosikowski, D Schuurhuis, K Johnson, et al.
Biochemical Pharmacology
|
May 11, 1995
Azatoxin derivatives with potent and selective action on topoisomerase II
F Leteurtre, D L Sackett, J Madalengoitia, et al.
Biochemical Pharmacology
|
October 7, 1994
Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin
K Gharehbaghi, A Sreenath, Z Hao, et al.
Journal of the National Cancer Institute
|
July 19, 1989
Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm
K D Paull, R H Shoemaker, L Hodes, et al.
Page
of 6